Fractyl
Lisa Davidson is Chief Financial Officer of Fractyl. Lisa has more than twenty-five years of broad corporate finance experience encompassing treasury management, strategic planning, operations finance, and controllership.
She served as Vice President of Finance & Administration of Flexion Therapeutics, Inc. Prior to Flexion, Lisa served as Director of Finance at OmniSonics Medical Technologies, Inc.
She previously served in various finance, strategy, and administration positions at PerkinElmer Inc., Pepsi Bottling Group, and Fisher Scientific International, Inc. (now part of ThermoFisher Scientific). Lisa has been involved in a number of M&A transactions, venture debt and equity financings, and numerous product launches. She holds both a B.A. and an MBA from the University of New Hampshire.
This person is not in any offices
Fractyl
2 followers
Fractyl aims to bring curative therapies to the large populations of patients with metabolic disease. With their innovative products, their goal is to truly shift the treatment paradigm for patients with metabolic disease by focusing on their root cause in the intestine to provide meaningful, transformative, benefits to restore patient health from metabolic diseases.